Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

DURACON MODULAR FEMORAL COMPONENT AND FEMORAL SPAC

K-Number: K920034 · 1992-03-18

ApplicantPfizer Hospital Products Group, Inc.
Decision Date1992-03-18
Product CodeJWH
Advisory CommitteeOR
DecisionSubstantially Equivalent

Device Summary

DURACON MODULAR FEMORAL COMPONENT AND FEMORAL SPAC is the device name listed in this FDA 510(k) record. The listed applicant is Pfizer Hospital Products Group, Inc.. It received FDA 510(k) clearance on 1992-03-18 under 510(k) number K920034. The device is classified under product code JWH. It was reviewed by the OR advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the DURACON MODULAR FEMORAL COMPONENT AND FEMORAL SPAC?

DURACON MODULAR FEMORAL COMPONENT AND FEMORAL SPAC is a medical device that received FDA 510(k) clearance on 1992-03-18. The listed applicant is Pfizer Hospital Products Group, Inc.. The 510(k) number is K920034.

When did DURACON MODULAR FEMORAL COMPONENT AND FEMORAL SPAC receive FDA 510(k) clearance?

DURACON MODULAR FEMORAL COMPONENT AND FEMORAL SPAC received FDA 510(k) clearance on 1992-03-18, under 510(k) number K920034.

Who is the listed applicant for DURACON MODULAR FEMORAL COMPONENT AND FEMORAL SPAC?

The FDA 510(k) record lists Pfizer Hospital Products Group, Inc. as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for DURACON MODULAR FEMORAL COMPONENT AND FEMORAL SPAC?

The FDA product code for DURACON MODULAR FEMORAL COMPONENT AND FEMORAL SPAC is JWH.

Related Clinical Trials

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

NCT07608549FLASH Pilot Phase 1 Safety StudyNOT_YET_RECRUITINGNCT06562205PAP Systems External Clinical Studies (ECS)NOT_YET_RECRUITINGNCT06443177The Effect of Sympathetic Modulation on Cerebral Vasospasm Secondary to Aneurysmal Subarachnoid HemorrhageSUSPENDEDNCT07095751Artificial Intelligence-assisted Uro-Cam Catheter Assessment System for Diagnosing Bladder CancerNOT_YET_RECRUITING

Other records listing Pfizer Hospital Products Group, Inc. as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K930156MEGA PLUS SUPER LAG SCREWK915512DURACON TOTAL KNEE SYSTEM TIBIAL COMPONENTSK920831PCA TOTAL HIP SYSTEM (CEMENTLESS USE)K915184HOWMEDICA ALUMINA FEMORAL HEADK911656PLEUR-EVAC PLUS CONTIN. REINFUS. & AUTOINFUS. SYSTK911292SCHNEIDER WALLSTENT(R)

View all 8 devices →

Related Devices (Code: JWH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

K262057GMK ExtensionMedacta International SAK260063GSPE SpacerThe General Hospital Corporation, d/b/a MassachusettsK262293EVOLUTION MPX™ Total Knee SystemSuzhou Microport Orthorecon Co., Ltd.K262341b-ONE® Mobio™ Total Knee System Revision Cemented Tibial Augments, Stem Extensions and Press-Fit Stem ExtensionsB-One Ortho, Corp.K262130ATTUNE Revision Knee SystemDepuy Orthopaedics, Inc.K253961SK Knee SystemJust Medical Devices (Tianjin) Co., Ltd.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.

↑